| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 1,187,940 | 883,015 | 849,924 | 1,389,232 | | Cost of Revenue | 967,815 | 710,859 | 688,668 | 1,198,285 | | | Gross Profit | 220,125 | 172,156 | 161,256 | 190,947 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 132,358 | 125,325 | 119,022 | 127,255 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 17,951 | 17,369 | 17,169 | 17,406 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 69,816 | 29,462 | 25,065 | 46,286 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 69,816 | 29,462 | 25,065 | 46,286 | | Interest Expense | 2,704 | 2,892 | 2,757 | 2,414 | | Income Before Tax | 67,112 | 26,570 | 22,308 | 43,872 | | Income Tax Expense | 22,919 | 10,997 | 8,284 | 16,520 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 44,193 | 15,573 | 14,024 | 27,352 | | | Non-recurring Events | | Discontinued Operations |
-
| (18) | (3) | (23) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 44,193 | 15,555 | 14,021 | 27,329 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $44,193 | $15,555 | $14,021 | $27,329 |
|
0.14% Nasdaq 
0.10%
Income Statement
